Presentation TCT 2016 Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes Presenter: Michael J. Mullen November 01, 2016 REGISTER for free or LOG IN to view this content Stroke Structural Heart PFO/ASD Presentation TCT 2016 Up Next Presentation TCT 2016 First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF Presenter: Valluvan Jeevanandam November 01, 2016 More slides + Presentation TCT 2016 Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical) Presenter: William T. Abraham November 01, 2016 Presentation TCT 2016 Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator Presenter: Mark W.I. Webster November 01, 2016 We Recommend
Presentation TCT 2016 First-In-Human Study of the NuPulseCV iVAS for Treating Advanced CHF Presenter: Valluvan Jeevanandam November 01, 2016
Presentation TCT 2016 Non-Pharmacological Treatment of Fluid Overload in ADHF Patients (WhiteSwell Medical) Presenter: William T. Abraham November 01, 2016
Presentation TCT 2016 Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator Presenter: Mark W.I. Webster November 01, 2016